Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9898 | 1046 | 27.6 | 75% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2325 | 4032 | NOONAN SYNDROME//COSTELLO SYNDROME//THROMBOSPONDIN 1 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NOONAN SYNDROME | Author keyword | 445 | 76% | 29% | 308 |
2 | COSTELLO SYNDROME | Author keyword | 271 | 88% | 12% | 127 |
3 | LEOPARD SYNDROME | Author keyword | 103 | 78% | 7% | 68 |
4 | CARDIO FACIO CUTANEOUS SYNDROME | Author keyword | 102 | 89% | 4% | 47 |
5 | PTPN11 | Author keyword | 86 | 62% | 8% | 88 |
6 | PTPN11 GENE | Author keyword | 53 | 89% | 2% | 24 |
7 | RASOPATHY | Author keyword | 42 | 72% | 3% | 33 |
8 | SHOC2 | Author keyword | 32 | 85% | 2% | 17 |
9 | CARDIOFACIOCUTANEOUS SYNDROME | Author keyword | 32 | 80% | 2% | 20 |
10 | CFC SYNDROME | Author keyword | 31 | 92% | 1% | 12 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NOONAN SYNDROME | 445 | 76% | 29% | 308 | Search NOONAN+SYNDROME | Search NOONAN+SYNDROME |
2 | COSTELLO SYNDROME | 271 | 88% | 12% | 127 | Search COSTELLO+SYNDROME | Search COSTELLO+SYNDROME |
3 | LEOPARD SYNDROME | 103 | 78% | 7% | 68 | Search LEOPARD+SYNDROME | Search LEOPARD+SYNDROME |
4 | CARDIO FACIO CUTANEOUS SYNDROME | 102 | 89% | 4% | 47 | Search CARDIO+FACIO+CUTANEOUS+SYNDROME | Search CARDIO+FACIO+CUTANEOUS+SYNDROME |
5 | PTPN11 | 86 | 62% | 8% | 88 | Search PTPN11 | Search PTPN11 |
6 | PTPN11 GENE | 53 | 89% | 2% | 24 | Search PTPN11+GENE | Search PTPN11+GENE |
7 | RASOPATHY | 42 | 72% | 3% | 33 | Search RASOPATHY | Search RASOPATHY |
8 | SHOC2 | 32 | 85% | 2% | 17 | Search SHOC2 | Search SHOC2 |
9 | CARDIOFACIOCUTANEOUS SYNDROME | 32 | 80% | 2% | 20 | Search CARDIOFACIOCUTANEOUS+SYNDROME | Search CARDIOFACIOCUTANEOUS+SYNDROME |
10 | CFC SYNDROME | 31 | 92% | 1% | 12 | Search CFC+SYNDROME | Search CFC+SYNDROME |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FACIO CUTANEOUS SYNDROME | 119 | 59% | 13% | 132 |
2 | CFC SYNDROME | 111 | 83% | 6% | 63 |
3 | COSTELLO SYNDROME | 89 | 54% | 11% | 115 |
4 | CARDIOFACIOCUTANEOUS SYNDROME | 75 | 91% | 3% | 31 |
5 | PTPN11 MUTATIONS | 69 | 56% | 8% | 84 |
6 | MUTATIONS CAUSE NOONAN | 56 | 75% | 4% | 41 |
7 | CUTANEOUS SKELETAL SYNDROME | 49 | 94% | 2% | 17 |
8 | NOONAN SYNDROME | 47 | 27% | 14% | 148 |
9 | LEOPARD SYNDROMES | 45 | 94% | 2% | 16 |
10 | LEOPARD SYNDROME | 45 | 56% | 5% | 55 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines | 2010 | 91 | 110 | 95% |
Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations | 2012 | 27 | 39 | 97% |
The RASopathies | 2013 | 47 | 63 | 57% |
The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation | 2009 | 206 | 49 | 45% |
The RAS/MAPK syndromes: Novel roles of the RAS pathway in human genetic disorders | 2008 | 131 | 117 | 50% |
Noonan syndrome | 2014 | 3 | 40 | 98% |
Clinical manifestations of mutations in RAS and related intracellular signal transduction factors | 2011 | 28 | 60 | 78% |
Leopard syndrome | 2008 | 49 | 32 | 78% |
Noonan syndrome | 2007 | 81 | 36 | 94% |
Costello syndrome: An overview | 2003 | 100 | 43 | 93% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIPARTIMENTO BIOL CELLULARE NEUROSCI | 6 | 21% | 2.4% | 25 |
2 | DIPARTIMENTO EMATOL ONCOL MED MOL | 5 | 27% | 1.6% | 17 |
3 | IST CLIN PEDIAT | 4 | 18% | 2.1% | 22 |
4 | UNIV HOSP PRAGUE | 4 | 75% | 0.3% | 3 |
5 | HORMONIOS GENET MOL LIM 42UNIDADE ENDOCRIN | 2 | 67% | 0.2% | 2 |
6 | MAXILLA IAL SURG | 2 | 67% | 0.2% | 2 |
7 | SERV EPIDEMIOL CLIN DIFETTI CONGENITI | 2 | 43% | 0.3% | 3 |
8 | METAB BIOCHIM PATOL | 2 | 21% | 0.7% | 7 |
9 | UNIV HOSP MAGDEBURG | 2 | 20% | 0.7% | 7 |
10 | ENDOCRINOL GENET UNIT LIM 25 | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000179999 | SHP 2//SHP 1//GAB1 |
2 | 0.0000127667 | JUVENILE MYELOMONOCYTIC LEUKEMIA//JMML//JUVENILE MYELOMONOCYTIC LEUKAEMIA |
3 | 0.0000071316 | CUTIS VERTICIS GYRATA//CEREBRIFORM INTRADERMAL NEVUS//CEREBRIFORM INTRADERMAL NAEVUS |
4 | 0.0000060150 | NEUROFIBROMATOSIS TYPE 1//NF1//NEUROFIBROMATOSIS |
5 | 0.0000058222 | CHERUBISM//BROWN TUMOR//CENTRAL GIANT CELL GRANULOMA |
6 | 0.0000053877 | FARNESYLTHIOSALICYLIC ACID//SALIRASIB//ABT STRUKTURELLE BIOL |
7 | 0.0000047593 | KBG SYNDROME//AARSKOG SCOTT SYNDROME//FACIOGENITAL DYSPLASIA |
8 | 0.0000047100 | GAPO SYNDROME//IFAP SYNDROME//ICHTHYOSIS FOLLICULARIS |
9 | 0.0000044458 | MIRROR SYNDROME//PLEUROAMNIOTIC SHUNT//BALLANTYNE SYNDROME |
10 | 0.0000031745 | TURNER SYNDROME//TURNERS SYNDROME//ULLRICH TURNER SYNDROME |